Home › Funds › Atom Investors LP › ERAS

Atom Investors LP position in ERAS

ERASCA INC · Health Care

Atom Investors LP reported holding 549,915 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.55% of its reported portfolio and ranking #18 among its reported holdings. Atom Investors LP has disclosed ERAS holdings in 8 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)549.91K sh
Reported value held$8.06M
Portfolio Weight0.55%
First reportedQ1 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's ERAS position evolved

Atom Investors LP first disclosed a stake in ERAS in Q1 2024 at 50,533 shares (US$104K). The position peaked in Q3 2026 at 549,915 shares, worth US$8.1M. Across 8 filings, Atom Investors LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 549,915 shares valued at US$8.1M — an increase of 390,104 shares quarter over quarter.. Notable position changes include a 57% increase in Q2 2024 (shares rose 16% over the following quarter), a 54% trim in Q2 2026 (shares fell 20% over the following quarter), a 244% increase in Q3 2026 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 50.53K $104.10K New
Q2 2024 79.53K $187.69K Add
Q4 2024 775.42K $1.95M New
Q1 2025 810.46K $1.11M Add
Q2 2025 549.96K $698.45K Reduce
Q1 2026 345.59K $5.59M New
Q2 2026 159.81K $2.93M Reduce
Q3 2026 549.91K $8.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 74 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has Atom Investors LP held ERAS?

Atom Investors LP has disclosed ERAS holdings in 8 of the last 11 reported quarters, going back to Q1 2024.

What is Atom Investors LP's current position in ERAS?

As of Q3 2026, Atom Investors LP holds 549.91K shares of ERAS (ERASCA INC), valued at $8.06M, representing 0.55% of its reported portfolio and ranking #18.

Has Atom Investors LP been buying or selling ERAS?

In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in ERAS. The position peaked in Q3 2026 at 549.91K shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.